Citadel Advisors’s Stericycle Inc SRCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-22,200
Closed -$1.35M 15715
2024
Q3
$1.35M Sell
22,200
-61,000
-73% -$3.62M ﹤0.01% 6247
2024
Q2
$4.84M Buy
83,200
+33,500
+67% +$1.72M ﹤0.01% 3795
2024
Q1
$2.62M Sell
49,700
-15,400
-24% -$775K ﹤0.01% 5015
2023
Q4
$3.23M Buy
65,100
+35,100
+117% +$1.57M ﹤0.01% 4519
2023
Q3
$1.34M Buy
30,000
+16,700
+126% +$746K ﹤0.01% 5985
2023
Q2
$618K Buy
13,300
+4,100
+45% +$179K ﹤0.01% 7472
2023
Q1
$401K Buy
9,200
+5,100
+124% +$252K ﹤0.01% 8766
2022
Q4
$205K Sell
4,100
-9,700
-70% -$462K ﹤0.01% 10098
2022
Q3
$581K Sell
13,800
-8,500
-38% -$409K ﹤0.01% 8139
2022
Q2
$978K Sell
22,300
-9,000
-29% -$446K ﹤0.01% 7075
2022
Q1
$1.84M Buy
31,300
+200
+0.6% +$11.6K ﹤0.01% 6266
2021
Q4
$1.85M Buy
31,100
+10,500
+51% +$658K ﹤0.01% 6427
2021
Q3
$1.4M Buy
20,600
+6,100
+42% +$421K ﹤0.01% 7276
2021
Q2
$1.04M Sell
14,500
-60,800
-81% -$4.47M ﹤0.01% 8281
2021
Q1
$5.08M Buy
75,300
+31,200
+71% +$2.12M ﹤0.01% 4221
2020
Q4
$3.06M Sell
44,100
-14,900
-25% -$1.02M ﹤0.01% 4560
2020
Q3
$3.72M Sell
59,000
-2,500
-4% -$154K ﹤0.01% 3600
2020
Q2
$3.44M Buy
61,500
+47,900
+352% +$2.5M ﹤0.01% 3624
2020
Q1
$661K Sell
13,600
-6,700
-33% -$395K ﹤0.01% 6017
2019
Q4
$1.29M Sell
20,300
-35,500
-64% -$2.1M ﹤0.01% 5128
2019
Q3
$2.84M Buy
55,800
+20,800
+59% +$968K ﹤0.01% 3940
2019
Q2
$1.67M Sell
35,000
-24,200
-41% -$1.23M ﹤0.01% 4824
2019
Q1
$3.22M Sell
59,200
-2,700
-4% -$122K ﹤0.01% 3647
2018
Q4
$2.27M Sell
61,900
-9,000
-13% -$422K ﹤0.01% 3947
2018
Q3
$4.16M Buy
70,900
+13,800
+24% +$881K ﹤0.01% 3242
2018
Q2
$3.73M Buy
57,100
+40,500
+244% +$2.52M ﹤0.01% 3171
2018
Q1
$972K Sell
16,600
-8,100
-33% -$548K ﹤0.01% 4848
2017
Q4
$1.68M Sell
24,700
-7,300
-23% -$496K ﹤0.01% 3886
2017
Q3
$2.29M Sell
32,000
-400
-1% -$29.4K ﹤0.01% 3248
2017
Q2
$2.47M Sell
32,400
-15,300
-32% -$1.26M ﹤0.01% 2892
2017
Q1
$3.95M Sell
47,700
-17,800
-27% -$1.43M ﹤0.01% 2280
2016
Q4
$5.05M Buy
65,500
+1,100
+2% +$83.1K 0.01% 1995
2016
Q3
$5.16M Buy
64,400
+46,300
+256% +$4.19M 0.01% 1955
2016
Q2
$1.89M Sell
18,100
-7,300
-29% -$781K ﹤0.01% 2819
2016
Q1
$3.21M Buy
25,400
+2,000
+9% +$233K ﹤0.01% 2190
2015
Q4
$2.82M Buy
23,400
+4,700
+25% +$599K ﹤0.01% 2393
2015
Q3
$2.6M Buy
18,700
+5,900
+46% +$821K ﹤0.01% 2622
2015
Q2
$1.71M Sell
12,800
-1,100
-8% -$151K ﹤0.01% 3239
2015
Q1
$1.95M Buy
13,900
+5,400
+64% +$729K ﹤0.01% 3097
2014
Q4
$1.11M Buy
8,500
+2,900
+52% +$365K ﹤0.01% 3643
2014
Q3
$653K Sell
5,600
-2,800
-33% -$331K ﹤0.01% 4276
2014
Q2
$995K Buy
8,400
+400
+5% +$45.8K ﹤0.01% 3489
2014
Q1
$909K Sell
8,000
-3,900
-33% -$451K ﹤0.01% 3545
2013
Q4
$1.38M Sell
11,900
-5,100
-30% -$595K ﹤0.01% 2904
2013
Q3
$1.96M Buy
17,000
+8,200
+93% +$946K ﹤0.01% 2429
2013
Q2
$972K Buy
+8,800
New +$956K ﹤0.01% 3209

Other funds holding SRCL

Citadel Advisors's SRCL Position: Q4 2024 in Review

Citadel Advisors sold out of Stericycle Inc (SRCL) in Q4 2024, closing a stake of 566,590 shares — an estimated $34.6M sold.

Citadel Advisors first reported a position in SRCL in Q2 2013 and held it in 41 quarters. The position peaked at $38.4M in Q3 2017. 4 funds tracked by Wall St. Rank hold SRCL as of Q4 2024.

  • Citadel Advisors reported no remaining Stericycle Inc position as of Q4 2024 after selling out during the quarter.
  • Citadel Advisors sold 566,590 Stericycle Inc shares in Q4 2024, an estimated $34.6M.
  • Citadel Advisors first reported a position in Stericycle Inc in Q2 2013 and held it in 41 quarters.
  • Citadel Advisors's Stericycle Inc position peaked at $38.4M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Stericycle Inc as of Q4 2024.

Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.